Novel solid pharmaceutical composition comprising amisulpride

Details for Australian Patent Application No. 2004255504 (hide)

Owner Sanofi-Aventis

Inventors Andre, Frederic; Lewis, Gareth; Da Cruz, Henri; Ribardiere, Agnes; Denni, Michel; Mignonneau, Jerome

Agent Davies Collison Cave

Pub. Number AU-A-2004255504

PCT Pub. Number WO2005/004860

Priority 03/08409 09.07.03 FR

Filing date 8 July 2004

Wipo publication date 20 January 2005

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/004860 Priority application(s): WO2005/004860

3 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255515-Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof

2004255503-Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment